A significant effect of treatment for feeling ready to perform was identified [ F (2, 84.12) = 3.211, p = 0.045], with post-hoc comparisons identifying no significant difference between the active and placebo groups but the DHA-rich group (59.12) showed a trend towards being significantly less ready to perform than the EPA-rich group (66.65; p = 0.075) ( Figure 3 ).
We established a statistical trend for a gender effect influencing intensity ratings [ F (1, 55.03) = 3.11, p = 0.075].
Daily supplementation with 1500 mg/d DHA and 1860 mg/d EPA for six months in healthy older men and women increased thigh muscle volume (3.6%, 95% CI 0.2% to 7.0%, p < 0.05), handgrip strength (2.3 kg, 95% CI 0.8 to 3.7 kg, p < 0.05) and one-repetition muscle strength (4.0%, 95% CI 0.8% to 7.3%, p < 0.05) and showed a trend towards increased average isokinetic power (5.6%, 95% CI 0.6% to 11.7%, p = 0.075) compared to a control group [ 114 ].
Total weight gain from PND2 to PND33 showed a statistical trend ( p = 0.075) on the interactive effects of diet and probiotic, with CON piglets showing the greatest total body weight gain ( Figure 1 ).
Similarly, BMI approached significance ( p = 0.075), with a uOR of 1.06 ( p = 0.035), suggesting a potential trend whereby a higher BMI may be associated with increased odds of scoring at or above the EAT-26 clinical cutoff.
Cognitive Performance Supplementation with BR showed a trend for improved correct response percentage in the Stroop test from pre- to post-supplementation compared to PL ( p = 0.075, η 2 p = 0.14).
Δ12–6 weeks 4.9 pg/mL, p = 0.003) and an increasing trend in the VDCa group (Δ6 weeks–baseline −12.5 pg/mL vs. Δ12–6 weeks 9.7 pg/mL, p = 0.075) ( Figure 4 ). 3.6.
When controlling for additional predetermined covariates, there was a marginally significant effect on change in HCC ( p = 0.075) with a slightly lower reduction of HCC in TZ compared to PZ (mean change (95% CI): −4.6 (−7.0; −2.3) vs. −9.4 (−11.7; −7.0) pg/mg; p = 0.053).
Yet, a borderline significant decreased risk of T2D was observed for SNPs rs731710-A/G ( SLC7A5 ) and rs3783436-T/C ( SLC7A8 ) under a dominant model (OR = 0.73, 95% CI: 0.51–1.03; p = 0.076 and OR = 0.70, 95% CI: 0.48–1.04, p = 0.078, respectively). 3.3.
As illustrated in Figure 1 C, a reduced (close to significance) AUC was found for the September intervention group (135.5 ± 47.5 mmol/L*min for control, 89.7 ± 65.5 mmol/L*min for the September intervention group, p = 0.076). 3.2.
All results remained statistically significant except for PSE’s effect on TUG, which showed a trend toward significance ( p = 0.076) in the ITT analysis (see Supplementary Table S2 and Figures S1 and S2, Supplementary Materials ).
They did not obtain any statistical significance in the probiotic group versus the control group in Crohn’s disease ( Figure S2 ); however, their results were more promising in relation to UC, nearing significance ( p = 0.076), and the post hoc analyses showed that levels of faecal calprotectin were significantly reduced ( p < 0.015) in patients with UC who received the probiotic instead of the placebo.
In the overall score obtained in the KIDMED survey, a statistical trend was found between the two groups ( p = 0.076).
In addition, a lower value for total sitting time in males was very close to significance ( p = 0.076).
The frequency of milk and dairy product intake in subjects with non-frailty showed a decreasing trend ( p = 0.076), as did the intake of seaweed ( p = 0.054).
In addition, the four-way interaction between supplement, physical exercise, BMI, and time for waist circumference showed a trend toward significance ( p = 0.076, ES = 0.036), attributed to the reduction in the trained obese group and the absence of changes in the other groups.
After adjustment for transplant characteristics and parameters related to renal function, the association remained significant for Camões’ (regression coefficient: 17.418; 95% CI: 4.484–30.352; p = 0.007) and modified Fung’s (regression coefficient: 13.708; 95% CI: 1.003–26.414; p = 0.033) but only marginally significant for Fung’s (regression coefficient: 12.124; 95% CI: −1.126 to 25.375; p = 0.077). 4.
Between-group comparison of change scores approached significance: t(38) = −1.82, p = 0.077, Cohen’s d = −0.57.
The main findings of the current study reveal that a gluten-free (GF) meal is: (1) significantly ( p < 0.01) more thermogenic efficient compared to ultra-processed (PF; −41%) and unprocessed whole food (WF; −50%) meals, respectively; (2) WF meal consumption resulted in significantly ( p < 0.01) greater feelings of fullness compared to GF (+14.36%) and PF (+16.81%), respectively, and enhanced ( p < 0.05) palatability (taste of meal) compared to PF meal (+27.41%); and (3) there was a strong trend ( p = 0.077) for increased desire to eat following the PF compared to WF at 120 (+26.42%) and 180 (16.62%), respectively.
When the AL and CR rats were considered together, we found negative associations between the liver protein mass and Δ 15 N levels in the urine and plasma proteins (−0.65 ≤ R ≤ −0.35), and on the contrary, positive associations were found between the muscle protein mass and Δ 15 N levels that were highly significant ( p < 0.01) in cardiac and gastrocnemius muscles (0.40 ≤ R ≤ 0.62), but were only marginally significant in the soleus muscle ( R = 0.27, p = 0.077) ( Figure 2 ). δ 15 N was also measured for 11 transaminating (Ala, Asx, Glx, Gly, Pro, Ile, Leu, and Val), non-transaminating, and indispensable (Met, Phe and Lys) AA in tissue proteins from the small intestine, plasma, heart, and the gastrocnemius muscle; Δ 15 N was calculated by subtracting the δ 15 N value of their dietary counterpart.
Difference in PCSK9 levels, from baseline to 8 and 13 weeks, between the supplementation and placebo group showed a strong trend of PCSK9 decrease only in patients with favorable lipids changes in the supplemented group ( p = 0.077).
In the case of insulin, there were no statistically significant variations throughout the study, although it was close to being significant due to the effect of consuming OPO and SO ( p = 0.077).
For Bmal1 gene expression, photoperiod effects showed a trend for decreased expression under L6 conditions compared to L18 conditions at CT18 in STD-fed animals by Mann–Whitney test ( p = 0.077) ( Figure 2 A).
PCI showed a trend to be higher in the IMN group as compared with the non-IMN group attending to median (10 vs. 8) and categories ( p = 0.077), although statistical significance was not reached.
The simple-effects test showed that the P3a amplitude under high-calorie food in the NPSS-F group was much larger than that under low-calorie food ( p = 0.043), and the P3a amplitude in the control group under low-calorie food was larger (marginally significant) than that in the NPSS-F group ( p = 0.077) and the obese group ( p = 0.058).